• Critical Innovations

PleuraPath™ Thoracostomy System shown to be 19% more effective at blood removal

A recent article in the Journal of Thoracic Disease shows significant improvement in blood removal using the PleuraPath™ Thoracostomy System, when compared to a traditional chest tube, in a large-animal model of retained hemothorax. For most serious chest trauma, tube thoracostomy is the definitive treatment. However, traditional chest tubes fail to sufficiently remove blood in up to one-fifth of patients. This is the first published scientific paper describing the new and innovative PleuraPath™ Thoracostomy System. See full article here.

87 views0 comments

Recent Posts

See All

Critical Innovations is happy to announce that it recently signed a Cooperative Research and Development Agreement (CRADA) with the U.S. Army Combat Capabilities Development Command Chemical Biologica

Critical Innovations signed a new Cooperative Research and Development Agreement (CRADA) with the Naval Medical Center San Diego / Navy Medicine Readiness and Training Command San Diego. The company i